XTX Topco Ltd boosted its holdings in shares of Smith & Nephew plc (NYSE:SNN - Free Report) by 302.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 41,507 shares of the medical equipment provider's stock after buying an additional 31,186 shares during the quarter. XTX Topco Ltd's holdings in Smith & Nephew were worth $1,293,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. State Street Corp increased its holdings in shares of Smith & Nephew by 1.3% in the third quarter. State Street Corp now owns 143,846 shares of the medical equipment provider's stock valued at $4,479,000 after purchasing an additional 1,889 shares during the last quarter. Stifel Financial Corp acquired a new position in Smith & Nephew in the 3rd quarter valued at about $1,258,000. Quantinno Capital Management LP raised its holdings in Smith & Nephew by 29.3% in the 3rd quarter. Quantinno Capital Management LP now owns 53,226 shares of the medical equipment provider's stock valued at $1,657,000 after acquiring an additional 12,057 shares during the period. Point72 DIFC Ltd acquired a new stake in Smith & Nephew during the third quarter worth approximately $7,200,000. Finally, Atom Investors LP bought a new stake in shares of Smith & Nephew during the third quarter worth approximately $400,000. Institutional investors own 25.64% of the company's stock.
Analyst Ratings Changes
Several analysts recently issued reports on SNN shares. Berenberg Bank downgraded Smith & Nephew from a "buy" rating to a "hold" rating in a research note on Wednesday, November 6th. StockNews.com cut shares of Smith & Nephew from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, November 12th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Smith & Nephew from a "buy" rating to a "hold" rating in a research report on Friday, November 1st.
Read Our Latest Stock Report on SNN
Smith & Nephew Trading Down 0.4 %
Shares of NYSE:SNN traded down $0.12 during trading on Tuesday, reaching $25.69. 672,466 shares of the company traded hands, compared to its average volume of 862,616. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. Smith & Nephew plc has a 52 week low of $23.65 and a 52 week high of $31.72. The company's 50 day moving average is $26.94 and its two-hundred day moving average is $27.89.
Smith & Nephew Profile
(
Free Report)
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Recommended Stories
Before you consider Smith & Nephew, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew wasn't on the list.
While Smith & Nephew currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.